• 1. Department of Respiratory, Nuclear Corporation 416 Hospital, Chengdu, Sichuan 610051, P.R.China; 2. Department of Infectious Disease, West China Hospital, Sichuan Uniersity, Chengdu, Sichuan 610041, P.R.China; 3. Department of Respiratory, The First Affiliated Hospital, Chongqing Medical University, Chongqing 400016, P.R.China;
WU Lianan, Email: wangxiaohong416@163.com
Export PDF Favorites Scan Get Citation

【摘要】 目的  〖JP2〗研究质子泵抑制剂(PPI)是否为危重患者发生医院获得性肺炎的危险因素。 方法  收集2002年6月-2009年6月收治的198例重症患者资料,分为使用PPI组(96例)和未使用PPI组(102例)。采用logistic回归分析PPI使用情况和医院获得性肺炎的关系。 结果  使用PPI组肺炎的发生率较高(26.9%),尤其是PPI使用时间超过7 d者(37.5%)。在不同的多变量logistic回归模型中,分别用APACHE Ⅱ评分和入住重症监护室原因校正后,使用PPI以及使用天数均是医院获得性肺炎发生的危险因素(P=0.031,OR=2.230,95%CI:1.957~2.947;P=0.002,OR=1.824,95%CI:1.457~2.242)。 结论  长时间应用PPI可能是增加ICU患者发生医院获得性肺炎的一种风险因素。
【Abstract】 Objective  To identify whether proton pump inhibitors (PPI) is a risk factor of hospital-acquired pneumonia (HAP) in critical patients. Methods  The clinical data of the critical patients admitted to ICU from June 2002 to June 2009 were retrospectively analyzed. A total of 198 patients were divided into two groups: 96 in PPI group and 102 in non-PPI group. The relationship between PPI and HAP was analyzed by logistic regression. Results  The patients in PPI group had a higher risk of HAP (26.9%), especially who were treated with PPI more than 7 days (37.5%). Adjusted by APACHE Ⅱ score and reason for admission to ICU, PPI therapy and the using duration of PPI were both the risk factors of HAP in different multiple logistic models (P=0.031, OR=2.230, 95%CI: 1.957-2.947; P=0.002, OR=1.824, 95%CI: 1.457-2.242). Conclusion  Long-term use of PPI is a risk factor of HAP.

Citation: WANG Xiaohong,WANG Yu,WU Lianan. Relationship Between Using Proton Pump Inhibitors and the Hospital-acquired Pneumonia in Critical Patients. West China Medical Journal, 2010, 25(10): 1811-1812. doi: Copy